None listed
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1) Only adult men and women over 19 years old 2) Those who have complained of heartburn at least 6 months prior to Visit 1 3) No mucosal break was observed according to LA classification in the upper gastrointestinal endoscopy performed by the institution within 28 days before the start of investigational drug administration. 4) Those who have a GERD-Q questionnaire score of 8 or higher in the screening test 5) Those who complain of nighttime heartburn more than 3 times a week
Exclusion criteria
Exclusion criteria: 1) Those who cannot receive an upper gastrointestinal endoscopy 2) Upper gastrointestinal endoscopy shows esophageal stricture, gastrointestinal varices, Barrett's esophagus, active peptic ucler, GI bleeding, or eosinophilic esophagitis 3) Those who received surgery on esophagus, stomach or duodenum 4) Those who have hypersensitivity reactions to medicines for clinical trials 5) Pregnant women, lactating women
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Percentage of days without nocturnal heartburn symptom | — |
Secondary
| Measure | Time frame |
|---|---|
| Percentage of subjects whose nocturnal heartburn symptoms are subsided | — |
Countries
Korea, Republic of
Contacts
Inje University Haeundae Paik Hospital